Get all your news in one place.
100's of premium titles.
One app.
Start reading
Barchart
Barchart
Wajeeh Khan

Why Johnson & Johnson Is Sending Intuitive Surgical (ISRG) Stock Down Today

Intuitive Surgical (ISRG) shares ended in the red on July 22 after Johnson & Johnson (JNJ) secured marketing authorization from the U.S. Food and Drug Administration (FDA) for its new Ottava robotic surgical platform. This milestone marks JNJ’s debut into soft-tissue robotic surgery, directly challenging ISRG in its core market.

The announcement added to pressure on Intuitive Surgical stock, which was already down about 35% year-to-date heading into Wednesday.

Sign up to read this article
Read news from 100's of titles, curated specifically for you.
Already a member? Sign in here
Related Stories
Top stories on inkl right now
One subscription that gives you access to news from hundreds of sites
Already a member? Sign in here
Our Picks
Fourteen days free
Download the app
One app. One membership.
100+ trusted global sources.